← Human Trials & Peer-Reviewed Studies
Concurrent effects of high-intensity interval training and vitamin D supplementation on bone metabolism among women diagnosed with osteoporosis: a randomized controlled trial.
Plain-language guide to PMID 40259289 (2025): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 30 patients, osteoporosis and bone density.
Key Facts
- PMID
- 40259289
- Journal
- BMC musculoskeletal disorders
- Year
- 2025
- Study type
- Randomized Controlled Trial
- Authors
- Alghadir AH et al. (3 authors)
- DOI
- 10.1186/s12891-025-08275-x
- Registered trial
- NCT06624657
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc in the context of osteoporosis and bone density.
This study aimed to investigate the effects of 16-week high-intensity interval training (HIIT) and vitamin D supplementation on bone mineral density (BMD) in women with osteoporosis.
Why It Was Studied
In addition to nutritional supplements, exercise is considered an adjunct factor in safeguarding bone health.
The study protocol was retrospectively registered at 'ClinicalTrials.gov PRS' under the trial identifier NCT06624657, dated 1/10/2024.
Who Took Part
According to the abstract, 30 patients were involved.
By PubMed's age tags, the people studied were adults and middle-aged adults, women only.
This study used a four-arm pretest-posttest experimental randomized controlled design.
One hundred twenty sedentary women aged (30-50 years), diagnosed with osteoporosis were recruited in this study.
How the Study Was Run
In design terms this was a randomized study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Anthropometric measurements, BMD, and serum levels of vitamin 25-(OH) D, Osteocalcin, s-BAP, and calcium were estimated in all participants before and after exercise training.
What Was Measured
PubMed files the paper under topics including High-Intensity Interval Training, Vitamin D, Bone Density, Dietary Supplements, Osteoporosis, Combined Modality Therapy and Biomarkers.
The authors tagged it with the keywords 25-hydroxyvitamin D (25OH-D), Bone metabolism and Bone mineral density.
What This Means in Plain Language
The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 30 patients in people with osteoporosis and bone density.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2025 (BMC musculoskeletal disorders), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, Osteoporosis and bone density research.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.